Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 2Phase 2 2

Status

Completed 4Terminated 2

Sponsor Class

INDUSTRY 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 4Gynecologic 1

Conditions

Anemia 4Uterine Cervical Neoplasms 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Completed × epoetin beta × Clear all
NCT00776425 2017-07-02

A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

Hoffmann-La Roche

Phase 4 Completed
117 enrolled
Classical hematology

Anemia

NCT02554942 2016-11-02

A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors

Hoffmann-La Roche

Phase 4 Completed
28 enrolled
Classical hematology

Anemia

NCT02564094 2016-11-02

A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies

Hoffmann-La Roche

Phase 4 Completed
54 enrolled
Classical hematology

Anemia

NCT00046969 2013-05-30

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

National Cancer Institute (NCI)

Phase 4 Completed
450 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡